article thumbnail

Ophthalmic Drug Delivery Development – Trials and Tribulations workshop

pharmaphorum

Workshop will be on ‘Ophthalmic Drug Delivery Development – Trials and Tribulations’. Ophthalmic Drug Delivery is compelling for many reasons, including the major issue of patient compliance and tolerability of therapies. Hosted by Brian Levy, CEO, Ocunexus Therapeutics.

article thumbnail

Unlocking the potential of direct-to-patient as decentralised trials continue to grow

Pharmaceutical Technology

This challenging environment, in addition to the measures taken to restrict people’s movement in order to reduce the viruses spread, led to many of the vital clinical trials being carried out to shift towards decentralised trial procedures that utilised virtual medicine and direct-to-patient (DtP) drug delivery.

Trials 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Swissmedic approves Buvidal for the treatment of opioid dependence

The Pharma Data

Administration of Buvidal is restricted to healthcare professionals, increasing treatment compliance, and minimizing risks of diversion, misuse and pediatric exposure. Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals with Opioid Use Disorder: A Randomized Clinical Trial. About Camurus.

article thumbnail

BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC

The Pharma Data

With this acquisition we are expanding our product pipeline to include psychedelic therapeutics, incorporating elements of our IP around drug delivery technology in which we already have prototypes developed, which we believe will propel us towards clinical studies relatively quickly. Ahmad Doroudian, CEO of BetterLife.

article thumbnail

Skin Cancer Awareness Month 2024 and Insights from Medicus Pharma

XTalks

XTALKS WEBINAR: Enhancing Efficiency in Early-Phase Oncology Trials: Strategies for Accelerating Data Flow Live and On-Demand: June 24, 2024, at 11am EDT (4pm BST/UK) Register for this webinar today to gain insights into how you can navigate and overcome data flow challenges in early-phase oncology clinical trials.

article thumbnail

BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application

The Pharma Data

is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. About BetterLife Pharma Inc. BetterLife Pharma Inc. About Transcend Biodynamics.

article thumbnail

Thrombocytopenia Drugs Market: What Newer Agents Are Expected To Enter The Market?

Delveinsight

There are newer agents coming to the market, for instance, Fc receptor via monoclonal IgG antibodies mechanism, BTK [Bruton tyrosine kinase] inhibition, and so on, however, the real challenge lies in the compliance in terms of patients perspectives such as cost and tolerance.